Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03501706 · ClinicalTrials.gov registry record · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
A NA study of Delay Discounting, sponsored by University of Kansas.
- Recruiting
- Registry status
- NA
- Development phase
- 680
- Enrollment target
- 1
- Study location
NCT03501706: Recruiting NA study of Delay Discounting, sponsored by University of Kansas.
NCT03501706 is a NA study of Delay Discounting that is actively recruiting participants, run by University of Kansas. The registered enrollment target is 680 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03501706, a NA study of Delay Discounting, is actively recruiting participants, sponsored by University of Kansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 680 participants
- Enrollment target
- 1
- Study location
Study Summary
Many health-relevant decisions involve intertemporal (now vs. later) tradeoffs. Extensive literature indicates that many negative health and financial consequences suffered in mid-life are linked to adversity and disadvantage during early developmental periods of life. Individuals who continue to engage in these types of unhealthy behaviors despite awareness of the health consequences are exhibiting an inability to delay gratification. Delay discounting (DD) is quantified in human studies by determining the rate at which an individual discounts a delayed reward, while executive function (EF) is defined as the set of cognitive processes that are responsible for helping individuals manage life tasks and achieve goals. This research will attempt to reduce DD via EF training in a population of mid-life individuals with risk factors established during early-life disadvantage.
Conditions Studied
Interventions
- BEHAVIORAL Sequenced Recall of Digits--Auditory
- BEHAVIORAL Sequenced Reverse Recall of Digits--Auditory
- BEHAVIORAL Sequenced Recall of Words--Visual
- BEHAVIORAL Verbal Memory--Visual
Study Locations (1)
Maryland
- University of Kansas-Lawrence - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2014-11-01 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
What NCT03501706 shows while recruiting
NCT03501706 is an interventional study that assigns participants to a tested intervention. The registered 680 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Delay Discounting appearing as the primary indexed condition, and to 4 interventions - of which Sequenced Recall of Digits--Auditory is the first listed.
NCT03501706 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03501706 about?
NCT03501706 is a clinical study titled "An Assessment of Cognitive Improvement Training Among Mid-life Individuals". Many health-relevant decisions involve intertemporal (now vs. later) tradeoffs. Extensive literature indicates that many negative health and financial consequences suffered in mid-life are linked to adversity and disadvantage during early developmental periods of life. Individuals who continue to en...
What is the current status of trial NCT03501706?
This trial is currently recruiting. It is a NA study. The enrollment target is 680 participants. The study started on 2014-11-01. Estimated completion is 2024-07-31.
What conditions does trial NCT03501706 study?
This clinical trial studies the following conditions: Delay Discounting.
What interventions are being tested in trial NCT03501706?
The interventions under investigation include: Sequenced Recall of Digits--Auditory (BEHAVIORAL), Sequenced Reverse Recall of Digits--Auditory (BEHAVIORAL), Sequenced Recall of Words--Visual (BEHAVIORAL), Verbal Memory--Visual (BEHAVIORAL).
Who is sponsoring clinical trial NCT03501706?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03501706 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03501706's enrollment target sits among peer trials
680 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- NCT05952141 · 680 participants · NA
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
- NCT06112314 · 680 participants · Phase 3
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI